XML 79 R55.htm IDEA: XBRL DOCUMENT
v3.21.2

Legal Proceedings (Details) $ in Millions |  | 1 Months Ended | 9 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | ---
Jan. 20, 2020 USD ($) | Oct. 31, 2021 USD ($) vote | Jun. 30, 2021 USD ($) | Jun. 28, 2020 USD ($) | Jan. 31, 2020 USD ($) | Oct. 31, 2019 USD ($) | Jul. 31, 2018 USD ($) | Oct. 03, 2021 USD ($) claimant patient | May 31, 2021 claimant | Oct. 31, 2020 USD ($) | Apr. 30, 2015 claim
ASR |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 300 |  |  |
Pinnacle Acetabular Cup System |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 5,400 |  |  |
Pelvic Meshes |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 10,700 |  |  |
Risperdal |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 9,000 |  |  |
XARELTO® |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 6,600 |  |  |
Talc |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 38,200 |  |  |
Invokana |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 100 |  |  |
Physiomesh |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 4,700 |  |  |
Opioid |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 3,300 |  |  |
Contact Lenses |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Number of pending claims | claim |  |  |  |  |  |  |  |  |  |  | 30
Settled Litigation | Opioid |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Damages awarded |  |  | $ 5,000.0 |  |  |  |  |  |  |  |
Damages awarded, including settlement for related issues, reimbursement for legal fees, and removal from related claims |  |  | 263.0 |  |  |  |  |  |  |  |
Settled Litigation | Opioid | Subsequent Event |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Damages awarded |  | $ 5,000.0 |  |  |  |  |  |  |  |  |
Damages awarded, including settlement for related issues, reimbursement for legal fees, and removal from related claims |  | 297.0 |  |  |  |  |  |  |  |  |
Judicial Ruling |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Damages awarded |  |  |  |  | $ 6.8 | $ 8,000.0 |  |  |  |  |
Pending Litigation |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Loss contingency, estimate of possible loss |  |  |  |  |  | $ 4,000.0 |  |  |  | $ 5,000.0 |
Loss contingency, estimate of additional possible loss |  |  |  |  |  |  |  |  |  | $ 1,000.0 |
Pending Litigation | Physiomesh |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  |  | 3,600 |  |
Pending Litigation | Opioid | State Level Jurisdiction |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 390 |  |  |
Pending Litigation | Opioid | Federal Level Jurisdiction |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Product liability contingency, number of claimants | claimant |  |  |  |  |  |  |  | 2,900 |  |  |
DePuy ASR U.S. | Settled Litigation |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Number of patients in settlement | patient |  |  |  |  |  |  |  | 10,000 |  |  |
Baby Powder | Talc | Subsequent Event |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Reserve established |  | 2,000.0 |  |  |  |  |  |  |  |  |
Litigation charge |  | $ 1,400.0 |  |  |  |  |  |  |  |  |
Number of votes in favor | vote |  | 16,000 |  |  |  |  |  |  |  |  |
Number of votes rejected | vote |  | 1,500 |  |  |  |  |  |  |  |  |
Baby Powder | Judicial Ruling | Damages from Product Defects |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Litigation contingency |  |  |  | $ 2,100.0 |  |  | $ 4,700.0 |  |  |  |
Payments for legal settlements |  |  | $ 2,500.0 |  |  |  |  |  |  |  |
Oklahoma Attorney General vs. Johnson & Johnson and JPI | Settled Litigation |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Damages awarded |  |  |  |  |  |  |  | $ 465.0 |  |  |
Surgical Mesh Products Marketing | Judicial Ruling |  |  |  |  |  |  |  |  |  |  |
Legal Proceeding (Textuals) |  |  |  |  |  |  |  |  |  |  |
Damages awarded | $ 344.0 |  |  |  |  |  |  |  |  |  |

X
- Definition Legal Proceeding Textuals Abstract. + References No definition available. + Details
Name: | jnj_LegalProceedingTextualsAbstract
Namespace Prefix: | jnj_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Damages Awarded, Additional Reimbursement, Value + References No definition available. + Details
Name: | jnj_LossContingencyDamagesAwardedAdditionalReimbursementValue
Namespace Prefix: | jnj_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Loss Contingency, Estimate of Additional Possible Loss + References No definition available. + Details
Name: | jnj_LossContingencyEstimateOfAdditionalPossibleLoss
Namespace Prefix: | jnj_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Loss Contingency, Number of Votes in Favor + References No definition available. + Details
Name: | jnj_LossContingencyNumberOfVotesInFavor
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Number of Votes Rejected + References No definition available. + Details
Name: | jnj_LossContingencyNumberOfVotesRejected
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Reserve Established within Trust + References No definition available. + Details
Name: | jnj_LossContingencyReserveEstablishedWithinTrust
Namespace Prefix: | jnj_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of patients in settlement + References No definition available. + Details
Name: | jnj_Numberofpatientsinsettlement
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Product liability contingency number of claimant. + References No definition available. + Details
Name: | jnj_ProductLiabilityContingencyNumberOfClaimant
Namespace Prefix: | jnj_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of damages awarded to the plaintiff in the legal matter. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 + Details
Name: | us-gaap_LossContingencyDamagesAwardedValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 + Details
Name: | us-gaap_LossContingencyDamagesSoughtValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Reflects the estimated amount of loss from the specified contingency as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248 + Details
Name: | us-gaap_LossContingencyEstimateOfPossibleLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of pending claims pertaining to a loss contingency. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349 + Details
Name: | us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585 + Details
Name: | us-gaap_PaymentsForLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_AsrMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_PelvicMeshesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_RisperdalMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_XareltoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_TalcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_InvokanaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_PhysiomeshMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_OpioidMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=jnj_ContactLensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | jnj_LegalJurisdictionAxis=jnj_StateLevelJurisdictionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | jnj_LegalJurisdictionAxis=jnj_FederalLevelJurisdictionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_BabyPowderMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_DamagesFromProductDefectsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=jnj_SurgicalMeshProductsMarketingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |